EV/EBITDA:
106.55+1.01(+0.96%)Summary
- As of today (June 24, 2025), PTGX EV/EBITDA is 106.55, with a rise of +1.01 (+0.96%) during the current trading session.
- Over the past year, PTGX EV/EBITDA has increased by +95.87 (+897.66%).
- PTGX EV/EBITDA is now -9.33% below its all-time high of 117.52.
Performance
PTGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PTGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.0% | +1.0% | +0.9% |
| 1 m1 month | +18.8% | +18.8% | +17.9% |
| 3 m3 months | +2.7% | +2.7% | +2.5% |
| 6 m6 months | +635.8% | +45.6% | +37.0% |
| ytdytd | +1101.2% | +41.4% | +39.5% |
| 1 y1 year | +897.7% | +97.8% | +68.2% |
| 5 y5 years | +1518.8% | +428.6% | +203.9% |
PTGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 111.73 | -4.6% | 89.70 | +18.8% |
| 3 m | 3-month | 111.73 | -4.6% | 79.81 | +33.5% |
| 6 m | 6-month | 117.52 | -9.3% | 8.08 | +1218.7% |
| 1 y | 1-year | 117.52 | -9.3% | 8.08 | +1218.7% |
| 3 y | 3-year | 117.52 | -9.3% | -19.12 | +657.3% |
| 5 y | 5-year | 117.52 | -9.3% | -30.57 | +448.5% |
| alltime | all time | 117.52 | -9.3% | -30.57 | +448.5% |
PTGX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 106.55(+1101.2%) |
| 2024 | 8.87(-170.5%) |
| 2023 | -12.59(+308.8%) |
| 2022 | -3.08(-75.1%) |
| 2021 | -12.37(-1.2%) |
| Date | Value |
|---|---|
| 2020 | -12.52(+435.0%) |
| 2019 | -2.34(+24.5%) |
| 2018 | -1.88(-79.3%) |
| 2017 | -9.10(-15.1%) |
| 2016 | -10.72 |
FAQ
- What is Protagonist Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Protagonist Therapeutics?
- What is PTGX EV/EBITDA year-to-date change?
- What is Protagonist Therapeutics EV/EBITDA year-on-year change?
What is Protagonist Therapeutics EV/EBITDA?
The current EV/EBITDA of PTGX is 106.55
What is the all time high EV/EBITDA for Protagonist Therapeutics?
Protagonist Therapeutics all-time high EV/EBITDA is 117.52
What is PTGX EV/EBITDA year-to-date change?
Protagonist Therapeutics EV/EBITDA has changed by +97.68 (+1101.24%) since the beginning of the year
What is Protagonist Therapeutics EV/EBITDA year-on-year change?
Over the past year, PTGX EV/EBITDA has changed by +95.87 (+897.66%)